drugset
drugset / Trial / NCT06658353

Phase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumors

NCT06658353 ↗

Phase 3 Recruiting 54 enrolled Jiangsu vcare pharmaceutical technology co., LTD
NaSingle-groupOpen-labelTreatment

Summary

This Study is a single arm, open label, multicenter phase III clinical trial to evaluate the safety and efficacy of VC004 in patients with locally advanced/metastatic solid tumors.

Timeline

Start
2025-03-17
Primary completion
2026-12-30
Completion
2026-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject VC004 Unknown — —

Indications

No indication recorded.